MedPath
HSA Approval

LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML

SIN14903P

LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML

LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML

December 15, 2015

LOTUS INTERNATIONAL PTE. LTD.

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLOTUS INTERNATIONAL PTE. LTD.
Licence HolderLOTUS INTERNATIONAL PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01ED51

timolol, combinations

Manufacturer Information

LOTUS INTERNATIONAL PTE. LTD.

Rafarm S.A

Active Ingredients

TIMOLOL MALEATE 6.83 mg/ml EQV TIMOLOL

5 mg/ml

Timolol

DORZOLAMIDE HYDROCHLORIDE 22.26 mg/ml EQV DORZOLAMIDE

20 mg/ml

Dorzolamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML - HSA Approval | MedPath